Orbis established the Green Vision Center (GVC) in Satara, Maharashtra, in collaboration with the PBMA's H V Desai Eye Hospital. The center's mission is to provide primary eye care and quality optical services to the communities in an...
A person in the know informed sources that Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure, has filed data for its mRNA-based Omicron specific Covid-19 booster shot for approval to the drug regulator, despite an increase...
Sukino Healthcare Solutions, India's first comprehensive continuum of care provider for long-term healthcare management, has received a Rs. 50 crore Series-A private equity investment from Stakeboat Capital...
The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of....
In today's world, product safety has become a key priority for the pharmaceutical industry. As such, the use of smart packaging and related technologies has become increasingly important.
OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) in order to address the significant unmet need in this multibillion-dollar market, announced that its planned trial...
Eris Lifesciences Limited has revealed the purchase of nine dermatology brands from Dr Reddy's Laboratories for a total of Rs 2,750 million. The majority of the products are in cosmetology categories such as anti-acne, moisturisers, cleansers,...
Polyplus, a leading provider of advanced therapeutic medicinal product manufacturing solutions from research to commercial grade, is introducing a novel cationic lipid for lipid nanoparticle (LNP) formulation in mRNA therapeutic and vaccine...
Medivir AB, a pharmaceutical company focused on developing innovative cancer treatments in areas of high unmet medical need, announced that the first patient with hepatocellular carcinoma (HCC) has begun phase 2a treatment with the candidate drug...
Pfizer Inc agreed to extend its COVID-19 vaccine contract from 2023 to 2026 with the European Union, the sources reported, citing people with knowledge of the matter...
, CDSCO.jpg)
